相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ketoconazole in Cushing's Disease: Is It Worth a Try?
Frederic Castinetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study
Xavier Bertagna et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
Daniel Cuevas-Ramos et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?
M. Barbot et al.
PITUITARY (2014)
Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations
Annamaria Colao et al.
PITUITARY (2014)
Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists
R. van der Pas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Medical Treatment of Cushing's Disease
Richard A. Feelders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Outcome of Bilateral Adrenalectomy in Cushing's Syndrome: A Systematic Review
Katrin Ritzel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy
Maria Fleseriu et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease
Li Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Changes in heart valve structure and function in patients treated with dopamine agonists for prolactinomas, a 2-year follow-up study
Victoria Delgado et al.
CLINICAL ENDOCRINOLOGY (2012)
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
Camille Baudry et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4-and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours
U. Ploeckinger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review
Veronica A. Preda et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling
Lionel Budry et al.
GENES & DEVELOPMENT (2012)
Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion
C. de Bruin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Potential Role for Retinoic Acid in Patients with Cushing's Disease
Francesca Pecori Giraldi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Fluconazole inhibits human adrenocortical steroidogenesis in vitro
R. van der Pas et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Medical Management of Persistent and Recurrent Cushing Disease
Maria Fleseriu
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
Annamaria Colao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate
Jens Heyn et al.
PITUITARY (2012)
Anti-VEGF therapy in pituitary carcinoma
Leon D. Ortiz et al.
PITUITARY (2012)
Medical management of Cushing's disease: what is the future?
Maria Fleseriu et al.
PITUITARY (2012)
Treatment of Pituitary Neoplasms With Temozolomide A Review
Luis V. Syro et al.
CANCER (2011)
Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial
David A. Calhoun et al.
CIRCULATION (2011)
The incidence and prevalence of Cushing's disease may be higher than previously thought: results from a retrospective study in Iceland 1955 through 2009
Steinunn Arnardottir et al.
CLINICAL ENDOCRINOLOGY (2011)
Mortality and morbidity in Cushing's syndrome in New Zealand
Mark J. Bolland et al.
CLINICAL ENDOCRINOLOGY (2011)
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
Matthias Kroiss et al.
CLINICAL ENDOCRINOLOGY (2011)
The Calcium-Sensing Receptor: A Molecular Perspective
Aaron L. Magno et al.
ENDOCRINE REVIEWS (2011)
The role of somatostatin and dopamine D2 receptors in endocrine tumors
Federico Gatto et al.
ENDOCRINE-RELATED CANCER (2011)
Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome
Peter Kamenicky et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Hidenori Fukuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Management of Cushing disease
Nicholas A. Tritos et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
Troy H. Dillard et al.
PITUITARY (2011)
Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor
Ning-Ai Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Rosiglitazone Revisited An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality
Steven E. Nissen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study
Krystallenia I. Alexandraki et al.
CLINICAL ENDOCRINOLOGY (2010)
EFFICACY OF CABERGOLINE IN UNCURED (PERSISTENT OR RECURRENT) CUSHING DISEASE AFTER PITUITARY SURGICAL TREATMENT WITH OR WITHOUT RADIOTHERAPY
Anurag R. Lila et al.
ENDOCRINE PRACTICE (2010)
Ion Channels and Signaling in the Pituitary Gland
Stanko S. Stojilkovic et al.
ENDOCRINE REVIEWS (2010)
Cabergoline monotherapy in the long-term treatment of Cushing's disease
Ariane Godbout et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Pregnancy and pituitary disorders
Z. Karaca et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
H. Bode et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)
Possible Relevance between Prohormone Convertase 2 Expression and Tumor Growth in Human Adrenocorticotropin-Producing Pituitary Adenoma
Kazumi Iino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Role of the PPAR-gamma System in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal Cells
Massimo Mannelli et al.
NEUROENDOCRINOLOGY (2010)
Management of Dyslipidemia in Cushing's Syndrome
Yona Greenman
NEUROENDOCRINOLOGY (2010)
Medical Treatment of Cushing's Syndrome: Adrenal-Blocking Drugs and Ketaconazole
Richard A. Feelders et al.
NEUROENDOCRINOLOGY (2010)
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Richard A. Feelders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Lucio Vilar et al.
PITUITARY (2010)
Role of Receptor-Interacting Protein 140 in human fat cells
Niklas Mejhert et al.
BMC ENDOCRINE DISORDERS (2010)
Merits and pitfalls of mifepristone in Cushing's syndrome
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors
Fernando Colbari Amaral et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Treatment of Pituitary-Dependent Cushing's Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
M. Boscaro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas
Zhi Rong Qian et al.
MODERN PATHOLOGY (2009)
Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome
C. de Bruin et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas
Marta Labeur et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience
John T. Chow et al.
CLINICAL ENDOCRINOLOGY (2008)
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Late recurrences of Cushing's disease after initial successful transsphenoidal surgery
Chirag G. Patil et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement
B. M. K. Biller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Management of recurrent and refractory Cushing disease
Manish K. Aghi
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Mifepristone (RU 486) in Cushing's syndrome
Sarah Johanssen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Long-term treatment of central Cushing's syndrome with rosiglitazone
M. Morcos et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2007)
Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma
O. M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Corticotroph tumor progression after adrenalectomy in Cushing's disease:: A reappraisal of Nelson's syndrome
Guillaume Assie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas
Dalia L. Batista et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease
Steve Bilodeau et al.
GENES & DEVELOPMENT (2006)
Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans
Nancy Nader et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Long term control of hypercortisolism with fluconazole:: case report and in vitro studies
M Riedl et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
α1-adrenergic receptor antagonists:: Novel therapy for pituitary adenomas
MA Fernando et al.
MOLECULAR ENDOCRINOLOGY (2005)
Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells
J van der Hoek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Laparoseopic adrenalectomy for patients who have Cushing's syndrome
WF Young et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2005)
Regulation of ghrelin secretion by somatostatin analogs in rats
AP Silva et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Cushing's syndrome during pregnancy: Personal experience and review of the literature
JR Lindsay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
LJ Hofland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease
D Suri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Micrornas: Small RNAs with a big role in gene regulation
L He et al.
NATURE REVIEWS GENETICS (2004)
The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormone secretion
RD Murray et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Dopamine receptor expression and function in corticotroph pituitary tumors
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Mechanisms for pituitary tumorigenesis: the plastic pituitary
S Melmed
JOURNAL OF CLINICAL INVESTIGATION (2003)
Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand
SG Ren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
AP Heaney et al.
NATURE MEDICINE (2002)
Overexpression of the V3 vasopressin receptor in transgenic mice corticotropes leads to increased basal corticosterone
P René et al.
JOURNAL OF NEUROENDOCRINOLOGY (2002)
Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)
JW Chu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Econazole and miconazole inhibit steroidogenesis and disrupt steroidogenic acute regulatory (StAR) protein expression post-transcriptionally
LP Walsh et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2000)
Leukemia-inhibitory factor - Neuroimmune modulator of endocrine function
CJ Auernhammer et al.
ENDOCRINE REVIEWS (2000)
Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
M Rocheville et al.
SCIENCE (2000)
分享论文
